Correlation Between Visa and Celltrion Pharm
Can any of the company-specific risk be diversified away by investing in both Visa and Celltrion Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Celltrion Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and Celltrion Pharm, you can compare the effects of market volatilities on Visa and Celltrion Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Celltrion Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Celltrion Pharm.
Diversification Opportunities for Visa and Celltrion Pharm
-0.72 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Visa and Celltrion is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Celltrion Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Celltrion Pharm and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Celltrion Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Celltrion Pharm has no effect on the direction of Visa i.e., Visa and Celltrion Pharm go up and down completely randomly.
Pair Corralation between Visa and Celltrion Pharm
Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.3 times more return on investment than Celltrion Pharm. However, Visa Class A is 3.39 times less risky than Celltrion Pharm. It trades about 0.07 of its potential returns per unit of risk. Celltrion Pharm is currently generating about 0.01 per unit of risk. If you would invest 22,072 in Visa Class A on October 13, 2024 and sell it today you would earn a total of 8,699 from holding Visa Class A or generate 39.41% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 97.18% |
| Values | Daily Returns |
Visa Class A vs. Celltrion Pharm
Performance |
| Timeline |
| Visa Class A |
| Celltrion Pharm |
Visa and Celltrion Pharm Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Visa and Celltrion Pharm
The main advantage of trading using opposite Visa and Celltrion Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Celltrion Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Celltrion Pharm will offset losses from the drop in Celltrion Pharm's long position.| Visa vs. American Express | Visa vs. PayPal Holdings | Visa vs. Capital One Financial | Visa vs. Upstart Holdings |
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Celltrion Pharm as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Celltrion Pharm's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Celltrion Pharm's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Celltrion Pharm.
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |